Caplin Point Laboratories Ltd
Caplin Point Laboratories is engaged in the business of pharmaceuticals - producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas markets.
The Company is entering into the Regulated Markets for Injectables through its state of the art manufacturing facility, capable of handling Liquid Injectables in Vials, Ampoules, Lyophilized Vials and Ophthalmic dosages. The facility is approved by US FDA, EU-GMP, ANVISA-Brazil and INVIMA-Colombia.
- Market Cap ₹ 3,514 Cr.
- Current Price ₹ 465
- High / Low ₹ 686 / 176
- Stock P/E 15.6
- Book Value ₹ 140
- Dividend Yield 0.54 %
- ROCE 37.7 %
- ROE 30.8 %
- Face Value ₹ 2.00
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 52.21% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 36.69%
Cons
- No cons found. Suggest something.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
143 | 146 | 156 | 159 | 187 | 193 | 227 | 228 | 215 | 240 | 268 | 274 | |
95 | 93 | 100 | 101 | 123 | 125 | 156 | 160 | 161 | 168 | 181 | 190 | |
Operating Profit | 49 | 53 | 56 | 58 | 65 | 67 | 71 | 68 | 54 | 72 | 87 | 84 |
OPM % | 34% | 36% | 36% | 36% | 35% | 35% | 31% | 30% | 25% | 30% | 33% | 31% |
Other Income | 3 | 2 | 7 | 8 | 3 | 4 | 7 | 10 | 20 | 6 | 2 | 6 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Depreciation | 6 | 5 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 9 | 9 |
Profit before tax | 45 | 49 | 57 | 60 | 61 | 64 | 71 | 70 | 65 | 69 | 80 | 80 |
Tax % | 22% | 24% | 24% | 23% | 18% | 22% | 19% | 15% | 25% | 20% | 21% | 18% |
Net Profit | 35 | 37 | 44 | 46 | 50 | 50 | 57 | 59 | 49 | 55 | 57 | 64 |
EPS in Rs | 4.68 | 4.95 | 5.76 | 6.06 | 6.59 | 6.64 | 7.58 | 7.74 | 6.46 | 7.21 | 7.52 | 8.52 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
81 | 107 | 127 | 173 | 252 | 239 | 402 | 540 | 649 | 863 | 998 | |
72 | 96 | 105 | 137 | 192 | 175 | 276 | 345 | 417 | 602 | 701 | |
Operating Profit | 9 | 11 | 22 | 36 | 60 | 64 | 125 | 195 | 232 | 261 | 297 |
OPM % | 11% | 10% | 18% | 21% | 24% | 27% | 31% | 36% | 36% | 30% | 30% |
Other Income | 3 | 3 | 2 | 4 | 3 | 4 | 10 | 13 | 19 | 41 | 34 |
Interest | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Depreciation | 2 | 1 | 2 | 4 | 8 | 7 | 13 | 19 | 23 | 32 | 36 |
Profit before tax | 8 | 11 | 22 | 36 | 53 | 60 | 121 | 188 | 227 | 269 | 294 |
Tax % | 23% | 28% | 37% | 27% | 23% | 24% | 21% | 23% | 22% | 20% | |
Net Profit | 6 | 8 | 14 | 26 | 41 | 46 | 96 | 145 | 177 | 215 | 225 |
EPS in Rs | 0.83 | 1.06 | 1.85 | 3.42 | 5.43 | 6.05 | 12.65 | 19.15 | 23.35 | 28.42 | 29.71 |
Dividend Payout % | 361% | 38% | 27% | 23% | 18% | 20% | 12% | 10% | 9% | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 38% |
3 Years: | 29% |
TTM: | 19% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 52% |
3 Years: | 30% |
TTM: | 4% |
Stock Price CAGR | |
---|---|
10 Years: | 63% |
5 Years: | 19% |
3 Years: | -7% |
1 Year: | 55% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 39% |
3 Years: | 37% |
Last Year: | 31% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 51 | 90 | 15 | |
Reserves | 14 | 18 | 28 | 47 | 78 | 113 | 210 | 349 | 514 | 716 | 1,041 |
Borrowings | 10 | 7 | 5 | 3 | 2 | 2 | 1 | 1 | 1 | 39 | 22 |
33 | 67 | 87 | 115 | 134 | 137 | 133 | 136 | 213 | 356 | 196 | |
Total Liabilities | 71 | 107 | 135 | 180 | 229 | 267 | 358 | 500 | 743 | 1,126 | 1,274 |
25 | 28 | 33 | 102 | 113 | 144 | 152 | 169 | 227 | 272 | 263 | |
CWIP | 0 | 13 | 51 | 25 | 31 | 0 | 3 | 15 | 10 | 20 | 26 |
Investments | 1 | 1 | 1 | 0 | 0 | 0 | 17 | 47 | 70 | 61 | 21 |
45 | 66 | 50 | 52 | 85 | 122 | 186 | 269 | 436 | 772 | 964 | |
Total Assets | 71 | 107 | 135 | 180 | 229 | 267 | 358 | 500 | 743 | 1,126 | 1,274 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
14 | 28 | 32 | 60 | 50 | 42 | 68 | 66 | 83 | 45 | |
-7 | -16 | -45 | -44 | -23 | -6 | -36 | -69 | -100 | -54 | |
-0 | -1 | -1 | -6 | -9 | -14 | -7 | -12 | 90 | 80 | |
Net Cash Flow | 7 | 10 | -15 | 10 | 19 | 23 | 25 | -14 | 73 | 70 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Jun 2011 | Jun 2012 | Jun 2013 | Jun 2014 | Jun 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 31% | 52% | 64% | 68% | 62% | 69% | 64% | 49% | 38% | |
Debtor Days | 38 | 25 | 2 | 0 | 8 | 12 | 30 | 85 | 90 | 97 |
Inventory Turnover | 13.16 | 10.19 | 10.46 | 12.30 | 9.00 | 9.48 | 9.82 | 9.18 | 3.10 |
Documents
Add documentRecent announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 17 Feb
- Announcement under Regulation 30 (LODR)-Cessation 5 Feb
- OUTCOME OF THE BOARD MEETING 4 Feb
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 2 Feb
- Board Meeting Intimation for Un-Audited Financial Results For The Quarter/Nine Months Ended December 31, 2020 29 Jan
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2010 from bse